Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Benchtop-Sized Image Cytometry System Brings Advanced Cell Analysis into the Lab

By LabMedica International staff writers
Posted on 01 May 2012
The first months in a year bring with it the opportunity for biotech research and other life science laboratories to acquire a new, state-of-the-art benchtop-sized image cytometer for rapid cell characterization.

Image cytometry generates microscopic cellular images and uses image-processing techniques to quantify cell data. More...
The technique can be used to acquire fluorescent intensity data from labeled cell samples, as well as for gathering morphological information. These basic principles can be applied to systems designed for a wide range of applications, up to and including high throughput screening of cell samples.

In order to meet the increasing need for convenient assays that deliver detailed multiparameter cell data quickly at laboratory scale, GE Healthcare (Chalfont St. Giles, United Kingdom) has introduced the Cytell Image Cytometer.

This benchtop-sized image cytometer is able to measure more than 32 parameters in a single run. Red and blue lasers (640- and 488-nm excitation) and four detectors enable a wide range of dyes to be used, including acridine orange, GFP, FITC, Alexa FluorTM 488, Phycoerythrin (PE), Propidium iodide (PI), Cy3, Cy5, Alexa Fluor 647, Allophycocyanin (APC), Dy649, DRAQ7TM, Dy679, and Alexa Fluor 700 with simultaneous measurement of four fluorescent channels. This array enables the researcher to perform a multitude of analyses including cell count, cell viability, and apoptosis; cell surface marker assays; antibody detection assays; cell phenotype analysis; and cell subpopulation analysis. In addition, Cytell was designed as an open platform allowing the investigator to use in-house reagents, antibodies, and protocols through an intuitive and simple interface.

Data can be acquired for up to eight samples at a time, and results are delivered through an intuitive graphical interface in less than two-and-a-half minutes.

Dr. Amr Abid, general manager of cell technologies at GE Healthcare Life Sciences, said, “We believe that understanding life’s basic building block, the cell, is an essential first step in the development of new and more effective treatments for disease. The Cytell Image Cytometer complements our existing advanced cell imaging systems, the IN Cell Analyzer and the DeltaVision OMX, by providing a quick and simple option for cell analysis. It is often the small changes that make the difference, and we believe that the Cytell will help researchers save both time and money in an increasingly constrained funding environment.”

Related Links:
GE Healthcare


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.